05:47 PM EDT, 03/23/2026 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said late Monday it has commenced a best-efforts public offering of its common stock, or pre-funded warrants, and accompanying warrants exercisable for its common stock.

The offering is subject to conditions, and there can be no assurance about the closing date, actual size or terms of the offering, the company said.

Outlook Therapeutics ( OTLK ) said it plans to use the net proceeds for working capital and general corporate purposes.